{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T03:19:49Z","timestamp":1790133589870,"version":"4.0.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T00:00:00Z","timestamp":1547164800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1038\/s41375-018-0348-x","type":"journal-article","created":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T13:48:48Z","timestamp":1547214528000},"page":"1723-1735","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Genetic and transcriptional landscape of plasma cells in POEMS syndrome"],"prefix":"10.1038","volume":"33","author":[{"given":"Yuhei","family":"Nagao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Mimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Shiozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiko","family":"Oshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumasa","family":"Aoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsunori","family":"Saraya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Koide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Rizq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Nishijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Isshiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Kayamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chika","family":"Kawajiri-Manako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagisa","family":"Oshima-Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shokichi","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shio","family":"Mitsukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikako","family":"Ohwada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Iseki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonoko","family":"Misawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Miyano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3328-9571","authenticated-orcid":false,"given":"Osamu","family":"Ohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koutaro","family":"Yokote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiko","family":"Sakaida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Sanada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Iwama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seishi","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1175-226X","authenticated-orcid":false,"given":"Chiaki","family":"Nakaseko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,11]]},"reference":[{"key":"348_CR1","first-page":"543","volume":"13","author":"K Takatsuki","year":"1983","unstructured":"Takatsuki K, Sanada I. Plasma cell dyscrasia with polyneuropathy and endocrine disorder: clinical and laboratory features of 109 reported cases. Jpn J Clin Oncol. 1983;13:543\u201355.","journal-title":"Jpn J Clin Oncol"},{"key":"348_CR2","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1212\/WNL.34.6.712","volume":"34","author":"T Nakanishi","year":"1984","unstructured":"Nakanishi T, Sobue I, Toyokura Y, Nishitani H, Kuroiwa Y, Satoyoshi E, et al. The Crow-Fukase syndrome: a study of 102 cases in Japan. Neurology. 1984;34:712\u201320.","journal-title":"Neurology"},{"key":"348_CR3","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/jnnp-2011-301706","volume":"83","author":"S Nasu","year":"2012","unstructured":"Nasu S, Misawa S, Sekiguchi Y, Shibuya K, Kanai K, Fujimaki Y, et al. Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry. 2012;83:476\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"348_CR4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/00005792-198007000-00006","volume":"59","author":"PA Bardwick","year":"1980","unstructured":"Bardwick PA, Zvaifler NJ, Gill GN, Newman D, Greenway GD, Resnick DL. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature. Medicine. 1980;59:311\u201322.","journal-title":"Medicine"},{"key":"348_CR5","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/ajh.24171","volume":"90","author":"A Dispenzieri","year":"2015","unstructured":"Dispenzieri A. POEMS syndrome: update on diagnosis, risk-stratification, and management. Am J Hematol. 2015;90:951\u201362.","journal-title":"Am J Hematol"},{"key":"348_CR6","doi-asserted-by":"publisher","first-page":"e009157","DOI":"10.1136\/bmjopen-2015-009157","volume":"5","author":"S Misawa","year":"2015","unstructured":"Misawa S, Sato Y, Katayama K, Hanaoka H, Sawai S, Beppu M, et al. Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study. BMJ Open. 2015;5:e009157.","journal-title":"BMJ Open"},{"key":"348_CR7","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.bbmt.2018.01.026","volume":"24","author":"C Kawajiri-Manako","year":"2018","unstructured":"Kawajiri-Manako C, Sakaida E, Ohwada C, Miyamoto T, Azuma T, Taguchi J, et al. Efficacy and long-term outcomes of autologous stem cell transplantation in POEMS syndrome: a nationwide survey in Japan. Biol Marrow Transplant. 2018;24:1180\u20136.","journal-title":"Biol Marrow Transplant"},{"key":"348_CR8","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1182\/blood-2017-07-795385","volume":"131","author":"C Ohwada","year":"2018","unstructured":"Ohwada C, Sakaida E, Kawajiri-Manako C, Nagao Y, Oshima-Hasegawa N, Togasaki E, et al. Long-term evaluation of physical improvement and survival of autologous stem cell transplantation in POEMS syndrome. Blood. 2018;131:2173\u20136.","journal-title":"Blood"},{"key":"348_CR9","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1182\/blood-2007-12-126979","volume":"112","author":"D Abe","year":"2008","unstructured":"Abe D, Nakaseko C, Takeuchi M, Tanaka H, Ohwada C, Sakaida E, et al. Restrictive usage of monoclonal immunoglobulin lambda light chain germline in POEMS syndrome. Blood. 2008;112:836\u20139.","journal-title":"Blood"},{"key":"348_CR10","first-page":"Ecr02","volume":"89","author":"S Martin","year":"2004","unstructured":"Martin S, Labauge P, Jouanel P, Viallard JL, Piette JC, Sauvezie B. Restricted use of Vlambda genes in POEMS syndrome. Haematologica. 2004;89:Ecr02.","journal-title":"Haematologica"},{"key":"348_CR11","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s00277-012-1455-9","volume":"91","author":"J Li","year":"2012","unstructured":"Li J, Huang Z, Duan MH, Zhang W, Chen M, Cao XX, et al. Characterization of immunoglobulin lambda light chain variable region (IGLV) gene and its relationship with clinical features in patients with POEMS syndrome. Ann Hematol. 2012;91:1251\u20135.","journal-title":"Ann Hematol"},{"key":"348_CR12","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1200\/JCO.2011.38.9288","volume":"30","author":"S Nakayama-Ichiyama","year":"2012","unstructured":"Nakayama-Ichiyama S, Yokote T, Hirata Y, Iwaki K, Akioka T, Miyoshi T, et al. Multiple cytokine-producing plasmablastic solitary plasmacytoma of bone with polyneuropathy, organomegaly, endocrinology, monoclonal protein, and skin changes syndrome. J Clin Oncol. 2012;30:e91\u2013e94.","journal-title":"J Clin Oncol"},{"key":"348_CR13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.leukres.2016.09.017","volume":"50","author":"C Wang","year":"2016","unstructured":"Wang C, Huang XF, Cai QQ, Cao XX, Cai H, Zhou D, et al. Remarkable expression of vascular endothelial growth factor in bone marrow plasma cells of patients with POEMS syndrome. Leuk Res. 2016;50:78\u201384.","journal-title":"Leuk Res"},{"key":"348_CR14","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1038\/leu.2009.174","volume":"23","author":"R Fonseca","year":"2009","unstructured":"Fonseca R, Bergsagel PL, Drach J, Shaughnessy J, Gutierrez N, Stewart AK, et al. International Myeloma Working Group molecular classification of multiple myeloma: spotlight review. Leukemia. 2009;23:2210\u201321.","journal-title":"Leukemia"},{"key":"348_CR15","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1200\/JCO.2005.05.021","volume":"23","author":"PL Bergsagel","year":"2005","unstructured":"Bergsagel PL, Kuehl WM. Molecular pathogenesis and a consequent classification of multiple myeloma. J Clin Oncol. 2005;23:6333\u20138.","journal-title":"J Clin Oncol"},{"key":"348_CR16","doi-asserted-by":"publisher","first-page":"5573","DOI":"10.1182\/blood-2011-01-270140","volume":"117","author":"N Korde","year":"2011","unstructured":"Korde N, Kristinsson SY, Landgren O. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies. Blood. 2011;117:5573\u201381.","journal-title":"Blood"},{"key":"348_CR17","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1212\/WNL.0b013e318263c42b","volume":"79","author":"K Kanai","year":"2012","unstructured":"Kanai K, Sawai S, Sogawa K, Mori M, Misawa S, Shibuya K, et al. Markedly upregulated serum interleukin-12 as a novel biomarker in POEMS syndrome. Neurology. 2012;79:575\u201382.","journal-title":"Neurology"},{"key":"348_CR18","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S0161-5890(03)00002-6","volume":"39","author":"N Gupta-Rossi","year":"2003","unstructured":"Gupta-Rossi N, Storck S, Griebel PJ, Reynaud CA, Weill JC, Dahan A. Specific over-expression of deltex and a new Kelch-like protein in human germinal center B cells. Mol Immunol. 2003;39:791\u20139.","journal-title":"Mol Immunol"},{"key":"348_CR19","doi-asserted-by":"publisher","first-page":"8531","DOI":"10.1128\/MCB.25.19.8531-8540.2005","volume":"25","author":"J Kroll","year":"2005","unstructured":"Kroll J, Shi X, Caprioli A, Liu HH, Waskow C, Lin KM, et al. The BTB-kelch protein KLHL6 is involved in B-lymphocyte antigen receptor signaling and germinal center formation. Mol Cell Biol. 2005;25:8531\u201340.","journal-title":"Mol Cell Biol"},{"key":"348_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature10113","volume":"475","author":"XS Puente","year":"2011","unstructured":"Puente XS, Pinyol M, Quesada V, Conde L, Ordonez GR, Villamor N, et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature. 2011;475:101\u20135.","journal-title":"Nature"},{"key":"348_CR21","doi-asserted-by":"crossref","unstructured":"Ganapathi KA, Jobanputra V, Iwamoto F, Jain P, Chen J, Cascione L, et al. The genetic landscape of dural marginal zone lymphomas. Oncotarget. 2016;7:43052\u201361.","DOI":"10.18632\/oncotarget.9678"},{"key":"348_CR22","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1182\/blood.V124.21.3346.3346","volume":"124","author":"A Mikulasova","year":"2014","unstructured":"Mikulasova A, Walker BA, Wardell CP, Boyle EM, Murison A, Kufova Z, et al. Somatic mutation spectrum in monoclonal gammopathy of undetermined significance compared to multiple myeloma. Blood. 2014;124:3346. ASH meeting abstract","journal-title":"Blood"},{"key":"348_CR23","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nature09837","volume":"471","author":"MA Chapman","year":"2011","unstructured":"Chapman MA, Lawrence MS, Keats JJ, Cibulskis K, Sougnez C, Schinzel AC, et al. Initial genome sequencing and analysis of multiple myeloma. Nature. 2011;471:467\u201372.","journal-title":"Nature"},{"key":"348_CR24","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1182\/blood-2018-10-875138","volume":"132","author":"BA Walker","year":"2018","unstructured":"Walker BA, Mavrommatis K, Wardell CP, Ashby TC, Bauer M, Davies FE, et al. Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma. Blood. 2018;132:587\u201397.","journal-title":"Blood"},{"key":"348_CR25","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","volume":"371","author":"S Jaiswal","year":"2014","unstructured":"Jaiswal S, Fontanillas P, Flannick J, Manning A, Grauman PV, Mar BG, et al. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014;371:2488\u201398.","journal-title":"N Engl J Med"},{"key":"348_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/gad.200014.112","volume":"27","author":"C Keim","year":"2013","unstructured":"Keim C, Kazadi D, Rothschild G, Basu U. Regulation of AID, the B-cell genome mutator. Genes Dev. 2013;27:1\u201317.","journal-title":"Genes Dev"},{"key":"348_CR27","doi-asserted-by":"publisher","first-page":"4488","DOI":"10.1182\/blood-2009-12-257758","volume":"115","author":"F Palacios","year":"2010","unstructured":"Palacios F, Moreno P, Morande P, Abreu C, Correa A, Porro V, et al. High expression of AID and active class switch recombination might account for a more aggressive disease in unmutated CLL patients: link with an activated microenvironment in CLL disease. Blood. 2010;115:4488\u201396.","journal-title":"Blood"},{"key":"348_CR28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ccr.2013.12.015","volume":"25","author":"JG Lohr","year":"2014","unstructured":"Lohr JG, Stojanov P, Carter SL, Cruz-Gordillo P, Lawrence MS, Auclair D, et al. Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy. Cancer Cell. 2014;25:91\u2013101.","journal-title":"Cancer Cell"},{"key":"348_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7997","volume":"6","author":"BA Walker","year":"2015","unstructured":"Walker BA, Wardell CP, Murison A, Boyle EM, Begum DB, Dahir NM, et al. APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma. Nat Commun. 2015;6:6997.","journal-title":"Nat Commun"},{"key":"348_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ccr.2007.07.003","volume":"12","author":"JJ Keats","year":"2007","unstructured":"Keats JJ, Fonseca R, Chesi M, Schop R, Baker A, Chng WJ, et al. Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. Cancer Cell. 2007;12:131\u201344.","journal-title":"Cancer Cell"},{"key":"348_CR31","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.1182\/blood-2009-09-243535","volume":"115","author":"YN Demchenko","year":"2010","unstructured":"Demchenko YN, Glebov OK, Zingone A, Keats JJ, Bergsagel PL, Kuehl WM. Classical and\/or alternative NF-kappaB pathway activation in multiple myeloma. Blood. 2010;115:3541\u201352.","journal-title":"Blood"},{"key":"348_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3997","volume":"5","author":"N Bolli","year":"2014","unstructured":"Bolli N, Avet-Loiseau H, Wedge DC, Van Loo P, Alexandrov LB, Martincorena I, et al. Heterogeneity of genomic evolution and mutational profiles in multiple myeloma. Nat Commun. 2014;5:2997.","journal-title":"Nat Commun"},{"key":"348_CR33","doi-asserted-by":"publisher","first-page":"3911","DOI":"10.1200\/JCO.2014.59.1503","volume":"33","author":"BA Walker","year":"2015","unstructured":"Walker BA, Boyle EM, Wardell CP, Murison A, Begum DB, Dahir NM, et al. Mutational spectrum, copy number changes, and outcome: results of a sequencing study of patients with newly diagnosed myeloma. J Clin Oncol. 2015;33:3911\u201320.","journal-title":"J Clin Oncol"},{"key":"348_CR34","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1158\/1078-0432.CCR-15-2123","volume":"22","author":"RD Morin","year":"2016","unstructured":"Morin RD, Assouline S, Alcaide M, Mohajeri A, Johnston RL, Chong L, et al. Genetic landscapes of relapsed and refractory diffuse large B-Cell lymphomas. Clin Cancer Res. 2016;22:2290\u20132300.","journal-title":"Clin Cancer Res"},{"key":"348_CR35","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.tcb.2010.10.003","volume":"21","author":"N Naslavsky","year":"2011","unstructured":"Naslavsky N, Caplan S. EHD proteins: key conductors of endocytic transport. Trends Cell Biol. 2011;21:122\u201331.","journal-title":"Trends Cell Biol"},{"key":"348_CR36","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1016\/j.yexcr.2006.06.035","volume":"312","author":"M Pollmann","year":"2006","unstructured":"Pollmann M, Parwaresch R, Adam-Klages S, Kruse ML, Buck F, Heidebrecht HJ. Human EML4, a novel member of the EMAP family, is essential for microtubule formation. Exp Cell Res. 2006;312:3241\u201351.","journal-title":"Exp Cell Res"},{"key":"348_CR37","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1158\/0008-5472.CAN-07-6158","volume":"68","author":"YL Choi","year":"2008","unstructured":"Choi YL, Takeuchi K, Soda M, Inamura K, Togashi Y, Hatano S, et al. Identification of novel isoforms of the EML4-ALK transforming gene in non-small cell lung cancer. Cancer Res. 2008;68:4971\u20136.","journal-title":"Cancer Res"},{"key":"348_CR38","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.3945\/jn.109.117531","volume":"140","author":"H Chen","year":"2010","unstructured":"Chen H, Attieh ZK, Syed BA, Kuo YM, Stevens V, Fuqua BK, et al. Identification of zyklopen, a new member of the vertebrate multicopper ferroxidase family, and characterization in rodents and human cells. J Nutr. 2010;140:1728\u201335.","journal-title":"J Nutr"},{"key":"348_CR39","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.4161\/cc.24927","volume":"12","author":"C Rey","year":"2013","unstructured":"Rey C, Soubeyran I, Mahouche I, Pedeboscq S, Bessede A, Ichas F, et al. HIPK1 drives p53 activation to limit colorectal cancer cell growth. Cell Cycle. 2013;12:1879\u201391.","journal-title":"Cell Cycle"},{"key":"348_CR40","doi-asserted-by":"publisher","first-page":"832","DOI":"10.3892\/mmr.2014.2285","volume":"10","author":"Z Li","year":"2014","unstructured":"Li Z, Yang Z, Peng X, Li Y, Liu Q, Chen J. Nuclear factor-kappaB is involved in the protocadherin-10-mediated pro-apoptotic effect in multiple myeloma. Mol Med Rep. 2014;10:832\u20138.","journal-title":"Mol Med Rep"},{"key":"348_CR41","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/ng.2983","volume":"46","author":"K Wang","year":"2014","unstructured":"Wang K, Yuen ST, Xu J, Lee SP, Yan HH, Shi ST, et al. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nat Genet. 2014;46:573\u201382.","journal-title":"Nat Genet"},{"key":"348_CR42","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1182\/bloodadvances.2017009654","volume":"2","author":"A Nagy","year":"2018","unstructured":"Nagy A, Bhaduri A, Shahmarvand N, Shahryari J, Zehnder JL, Warnke RA, et al. Next-generation sequencing of idiopathic multicentric and unicentric Castleman disease and follicular dendritic cell sarcomas. Blood Adv. 2018;2:481\u201391.","journal-title":"Blood Adv"},{"key":"348_CR43","doi-asserted-by":"publisher","first-page":"6438","DOI":"10.1182\/blood-2010-11-316935","volume":"117","author":"LN Dao","year":"2011","unstructured":"Dao LN, Hanson CA, Dispenzieri A, Morice WG, Kurtin PJ, Hoyer JD. Bone marrow histopathology in POEMS syndrome: a distinctive combination of plasma cell, lymphoid, and myeloid findings in 87 patients. Blood. 2011;117:6438\u201344.","journal-title":"Blood"},{"key":"348_CR44","doi-asserted-by":"crossref","unstructured":"Kawajiri-Manako C, Mimura N, Fukuyo M, Namba H, Rahmutulla B, Nagao Y, et al. Clonal immunoglobulin lambda light-chain gene rearrangements detected by next generation sequencing in POEMS syndrome. Am J Hematol. 2018;93:1161\u201368.","DOI":"10.1002\/ajh.25213"},{"key":"348_CR45","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nature10496","volume":"478","author":"K Yoshida","year":"2011","unstructured":"Yoshida K, Sanada M, Shiraishi Y, Nowak D, Nagata Y, Yamamoto R, et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature. 2011;478:64\u201369.","journal-title":"Nature"},{"key":"348_CR46","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1038\/ng.2759","volume":"45","author":"K Yoshida","year":"2013","unstructured":"Yoshida K, Toki T, Okuno Y, Kanezaki R, Shiraishi Y, Sato-Otsubo A, et al. The landscape of somatic mutations in Down syndrome-related myeloid disorders. Nat Genet. 2013;45:1293\u20139.","journal-title":"Nat Genet"},{"key":"348_CR47","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJMoa1414799","volume":"373","author":"T Yoshizato","year":"2015","unstructured":"Yoshizato T, Dumitriu B, Hosokawa K, Makishima H, Yoshida K, Townsley D, et al. Somatic mutations and clonal hematopoiesis in aplastic anemia. N Engl J Med. 2015;373:35\u201347.","journal-title":"N Engl J Med"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41375-018-0348-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41375-018-0348-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41375-018-0348-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:36:32Z","timestamp":1684618592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-018-0348-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,11]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["348"],"URL":"https:\/\/doi.org\/10.1038\/s41375-018-0348-x","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,11]]},"assertion":[{"value":"12 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}